Hereditary factor VII deficiency: heterogeneity defined by combined functional and immunochemical analysis

Area of Science:

• Hematology
• Coagulation Disorders

Background:

• Hereditary factor VII deficiency is a rare bleeding disorder.
• Factor VII is a crucial clotting protein involved in hemostasis.

Purpose of the Study:

• To investigate the complex interactions between factor VII activity and thromboplastin assays.
• To determine which thromboplastin assay best correlates with clinical bleeding in factor VII deficiency.

Main Methods:

• Evaluated 26 patients with hereditary factor VII deficiency (VII:C < 10%).
• Utilized three thromboplastins (varying species/tissue origin) in coagulant and chromogenic assays.
• Measured factor VII antigen (VII:Ag) via radioimmunoassay.

Main Results:

• Patients were grouped by VII:Ag levels (decreased vs. normal).
• Discrepancies in VII:C levels were observed between assay systems.
• Factor VII activity measured with human thromboplastin correlated best with clinical bleeding history.

Conclusions:

• Factor VII and thromboplastin interactions are complex.
• Human thromboplastin assays are most clinically relevant for assessing bleeding risk in factor VII deficiency.